Pliant Therapeutics, Inc. PLRX
0.86 USD +0.02 (+2.56%)
At closeNov 3, 2026, 4:13 PM EST
0.87 +0.01 +1.08%
After hours · Nov 3, 4:13 PM ET
0.8352 Day range 0.8641
0.83 52-week range 1.82
- YTD
- -29.45%
- 1 year
- -48.46%
Analyst view
Price target (mean) 40.18 +4568.5% upside
Now 0.8607
- Target (low)
- 32.00
- Target (mean)
- 40.18
- Target (high)
- 47.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy5
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.97688 | -1.02 – -0.92 | -0.69 | -41.6% | 83.33K | 0.0% | 9 |
| Next quarter | -0.956 | -1.01 – -0.86 | -0.78 | -22.6% | 333.33K | 0.0% | 5 |
| Current year | -3.63 | -3.68 – -3.57 | -2.75 | -31.9% | 83.33K | -94.7% | 10 |
| Next year | -3.94 | -4.96 – -3.11 | -3.63 | -8.5% | 5.75M | +6800.3% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 8, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 8, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 8, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 16, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 7, 2024 | Citigroup | Maintained | Buy | Buy |
| May 7, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 7, 2024 | Needham | Reiterated | Buy | Buy |
| May 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 12, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 5, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 28, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 28, 2024 | Needham | Reiterated | Buy | Buy |
| Feb 5, 2024 | Needham | Maintained | Buy | Buy |
| Feb 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 10, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 4, 2023 | Needham | Reiterated | Buy | Buy |
| Sep 27, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 27, 2023 | Needham | Reiterated | Buy | Buy |
| Sep 15, 2023 | Needham | Reiterated | Buy | Buy |
| Aug 29, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |